Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internat…
Biotechnology
US, Novato [HQ]
Cash Flow Statements
13 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Cash Flow (OCF) | -5.00 | -12.00 | -31.00 | -44.00 | -105.00 | -160.00 | -253.00 | -290.00 | -345.00 | -132.00 | -338.00 | -380.00 | -474.00 | |
| Operating Cash (Net) | -5.00 | -12.00 | -31.00 | -44.00 | -105.00 | -160.00 | -253.00 | -290.00 | -345.00 | -132.00 | -338.00 | -380.00 | -474.00 | |
| Accounts Receivable | - - | - - | - - | - - | - - | - - | -5.00 | -7.00 | -20.00 | 9.00 | -5.00 | -12.00 | -22.00 | |
| Accounts Payable | - - | - - | - - | 3.00 | -1.00 | 2.00 | 3.00 | 3.00 | 20.00 | 29.00 | 2.00 | 87.00 | 2.00 | |
|
Working Capital
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Change | - - | 2.00 | -1.00 | 2.00 | 7.00 | 26.00 | -20.00 | -24.00 | -15.00 | 104.00 | -63.00 | 60.00 | -15.00 | |
| Other WC | - - | 1.00 | -1.00 | -1.00 | 9.00 | 23.00 | -23.00 | -15.00 | -12.00 | 66.00 | -57.00 | -5.00 | 12.00 | |
| Investing Activities | ||||||||||||||
| Used Cash (Net) | - - | -1.00 | -47.00 | -123.00 | -292.00 | 89.00 | 56.00 | -33.00 | -13.00 | -179.00 | -195.00 | -291.00 | 168.00 | |
| Capital Expenditure | - - | -1.00 | - - | -2.00 | -4.00 | -10.00 | -2.00 | -4.00 | -24.00 | -43.00 | -73.00 | -146.00 | -46.00 | |
| Purchases of Investments | - - | - - | -63.00 | -208.00 | -624.00 | -442.00 | -230.00 | -509.00 | -707.00 | -850.00 | -1,012.00 | -614.00 | -526.00 | |
| Sale/Maturity of Investment | - - | - - | 16.00 | 87.00 | 338.00 | 543.00 | 431.00 | 310.00 | 718.00 | 720.00 | 890.00 | 545.00 | 746.00 | |
| Property, Plant, Equipment (P&PE) | - - | -1.00 | - - | -2.00 | -4.00 | -10.00 | -2.00 | -4.00 | -24.00 | -43.00 | -73.00 | -146.00 | -46.00 | |
| Acquisitions (Net) | - - | - - | - - | - - | - - | - - | -142.00 | - - | -11.00 | - - | - - | -75.00 | -2.00 | |
| Other Investing Activities | - - | - - | - - | - - | -1.00 | -1.00 | - - | 170.00 | 11.00 | -5.00 | - - | - - | -2.00 | |
| Financing Activities | ||||||||||||||
| Used Cash (Net) | -17.00 | -89.00 | - - | -184.00 | -467.00 | -138.00 | -136.00 | -336.00 | -679.00 | -600.00 | -118.00 | -501.00 | -388.00 | |
| Debt Repayment | - - | - - | - - | - - | - - | - - | -4.00 | - - | -314.00 | - - | - - | -490.00 | - - | |
| Dividends Paid | - - | - - | - - | -4.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Common Stock
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Issued | - - | - - | - - | 189.00 | 467.00 | 79.00 | 131.00 | - - | 365.00 | 511.00 | 78.00 | 10.00 | 388.00 | |
| Repurchased | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Financing Activities | 17.00 | 89.00 | - - | 189.00 | 467.00 | 59.00 | 9.00 | 336.00 | 679.00 | 89.00 | 39.00 | 981.00 | 388.00 | |
| Cash Balances | ||||||||||||||
| Begin of Period | - - | 10.00 | 86.00 | 7.00 | 24.00 | 93.00 | 161.00 | 103.00 | 115.00 | 436.00 | 726.00 | 309.00 | 133.00 | |
| End of Period | 10.00 | 86.00 | 7.00 | 24.00 | 93.00 | 161.00 | 100.00 | 115.00 | 436.00 | 726.00 | 309.00 | 137.00 | 219.00 | |
| Change | 10.00 | 75.00 | -78.00 | 16.00 | 69.00 | 67.00 | -60.00 | 12.00 | 320.00 | 290.00 | -416.00 | -171.00 | 85.00 | |
| Non-Cash Balances | ||||||||||||||
| Depreciation and Amortization | - - | - - | - - | - - | 1.00 | 3.00 | 5.00 | 19.00 | 8.00 | 12.00 | 13.00 | 18.00 | 26.00 | |
| Stock Based Compensation | - - | - - | - - | 5.00 | 24.00 | 48.00 | 68.00 | - - | 81.00 | 85.00 | 104.00 | 130.00 | 135.00 | |
| Other | - - | - - | 4.00 | 6.00 | 5.00 | - - | 10.00 | - - | 1.00 | 21.00 | 11.00 | 119.00 | -12.00 | |
| Highlighted metrics | ||||||||||||||
| Free Cash Flow (FCF) | -6.00 | -13.00 | -31.00 | -46.00 | -110.00 | -171.00 | -256.00 | -294.00 | -370.00 | -176.00 | -411.00 | -526.00 | -521.00 | |
| Cash Conversion Cycle (CCC) | - - | - - | - - | - - | - - | - - | - - | -1,569.00 | 61.00 | 38.00 | 8.00 | -172.00 | -4.00 | |
| Invested Capital | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Other Operating Inflows/Outflows
|
||||||||||||||
| Forex Effect on Cash | - - | - - | - - | - - | - - | - - | - - | - - | - - | 1.00 | -1.00 | -1.00 | - - |